Special Report: Six Pot Stocks to Own in 2020

2018 was a banner year for pot stocks.

Canadian pot stocks in particular made early investors a ton of money after the country fully legalized cannabis. In some cases, we took gains in excess of 3,100%.

But the truth is the big money has now moved on to the next burgeoning market: the United States.

Thanks to a major shake-up in Washington and an avalanche of new state-based legalization efforts, a flood of new capital is pouring into the U.S. cannabis market in anticipation of the end of the federal prohibition on cannabis.

Make no mistake: The full-scale legalization of cannabis — on a federal level — is about to happen. And unless you hate money, you should absolutely have some portion of your portfolio reserved for U.S. pot stocks.

The entire framework for U.S. cannabis legalization is being built at this very moment. And in this report, I’ll reveal the names of six U.S. pot stocks that are primed for huge gains in the first half of 2020.

Time to Buy

In 2018, we saw U.S. cannabis stocks begin to move in unison with Canadian cannabis stocks, both before and after Canada’s legalization.

The result was a huge wave of profits for those who jumped in early.

But a lot has changed for pot stocks since that big run up.

The reality is, while there’s no greater investment opportunity today than in the legal cannabis market, at the start of 2019, most cannabis stocks were incredibly overvalued — in some cases by more than 60% to 70%.

For early investors who took their winnings off the table, this was a good thing. But for those who were late to the party, there were huge losses. The good news for you, however, is that the correction in cannabis stocks in 2019 has brought a series of fantastic buying opportunities.

Strong Momentum

Before we get into these individual stocks, let’s first take a look at why the U.S. cannabis market remains red-hot.

Although cannabis stocks began to correct earlier this year, the legalization movement has continued to gain traction.

On the legislative front, there are several cannabis-related bills getting a lot of support from lawmakers — on both sides of the aisle. Some of the more important ones include:

The SAFE Banking Act — allows cannabis businesses to use banking services, passed the House on September 25, 2019. If it also passes the Senate, this bill would be a major game changer, as access to banking services would allow the cannabis industry to tap into large pools of cheap money. It would also clear the way for dispensaries to use credit cards, which some believe would increase average consumer purchases by nearly 200%.

The Ensuring Safe Capital Access for All Small Businesses Act — would allow cannabis entrepreneurs to apply for small business administration (SBA) loans.

The STATES Act — would force the federal government to recognize and honor U.S. state laws regarding cannabis legalization.

It is likely that all three of these will pass by the end of the year, thereby laying the groundwork for full-scale federal decriminalization.

Other developments include:

  • 17 states have officially decriminalized cannabis.
  • 11 states, plus the District of Columbia, have officially legalized the recreational use of cannabis.
  • 33 states have officially legalized the medical use of cannabis.

Federal Reserve officials have pledged to tell banks they can serve hemp businesses.

Every Democrat running for president in 2020 is openly supporting decriminalization and legalization legislation.

Everything we’re seeing today is very similar to what we saw in Canada just two years prior to legalization:

  • Overwhelming support from voters.
  • Individual states (or in the case of Canada, provinces) backing legalization in an effort to increase tax revenues.
  • Billions of dollars being funneled into new cannabis ventures and lobbying efforts.
  • Election-time politicians using legalization as a way to garner votes.

Make no mistake: This IS happening. And in less than three years, there will no longer be any federal criminalization of cannabis. This is why there’s never been a better time to load up on these recently corrected U.S. cannabis stocks.

Buying on the Cheap

There are plenty of U.S. cannabis stocks to choose from, but at this point it’s all about bargain hunting and finding the best deal. And when it comes to “best deals,” we’re primarily focused on multi-state operators (MSOs). I’m talking about cannabis companies that are operational in multiple states.

Because the industry is still fragmented by state and the plant is still considered federally illegal, every state has its own set of rules and opportunities. But those companies already on the ground in multiple states will have a first-mover advantage once the federal prohibition of cannabis is lifted.

The following MSOs already have very large U.S. exposure, very deep pockets, are actively generating revenue, and are trading at significant discounts to their peers.

VIREO HEALTH (OTCBB: VREOF)

Footprint: 11 States + Puerto Rico

One-year price target: $6

ACREAGE HOLDINGS (OTCBB: ACRGF)

Footprint: 15 States

One-year price target: $19

CURALEAF HOLDINGS (OTCBB: CURLF)

Footprint: 11 States

One-year price target: $10

HARVEST HEALTH & RECREATION (OTCBB: HRVSF)

Footprint: Nine States

One-year price target: $9.25

IANTHUS (OTCBB: ITHUF)

Footprint: 12 States

One-year price target: $5

MARIMED INC. (OTCBB: MRMD)

Footprint: Eight States

One-year price target: $4.25

Easy Money

Although the lion’s share of cannabis profits will be made in the U.S. in 2020, there are also additional opportunities outside of the U.S.

Take Elixinol (OTCBB: ELLXF),for instance, which has excellent exposure in Australia. And Khiron Life Sciences (OTCBB: KHRNF), which is a solid play to capitalize on the Latin America market, is also growing rapidly, particularly with Mexico gearing up to legalize. And other countries such as Colombia, Uruguay, and Brazil are also making big moves in the production and export markets. The nice thing about Khiron is that the former president of Mexico, Vicente Fox, sits on the board of the company.

These Six Stocks Are Just the Beginning of the Cannabis Cash Windfall

The truth is the cannabis market is a global one, and it’s spreading rapidly. And while the big money is still in the U.S., keep a lookout for major legalization efforts to take hold in Latin America, the EU, Australia, and even China in the coming years.

As new developments unfold in any of these markets, you’ll want to stay on top of them because even a small delay in getting in on a stock while it climbs to the top could cost you thousands.

That’s why I want to take a moment to share some very exciting news.

Part of my duties as the in-house pot stock expert at Angel Publishing is to pinpoint new pot opportunities that could help investors rake in huge profits.

And I just identified three additional pot stocks that are primed to skyrocket from the onslaught of legalization efforts.

Quite frankly, at this point, it’s just easy money for investors who get into these three stocks early.

In fact, this is one of those opportunities I like to call a “Kennedy Event.”

Because just like how the Kennedy family amassed $16 million in wealth (the equivalent of over $300 million today) by bottling and storing liquor in preparation for the end of prohibition...

Investors who prepare for the end of marijuana’s prohibition could experience a windfall of the same kind of “Kennedy” wealth. This, in fact, is one of the biggest Kennedy-style profit opportunities you or I will see in our lifetimes.

It’s why I created "The Kennedy Blueprint: Three Millionaire-Maker Stocks for The End of Pot Prohibition."

This report details the full opportunity and my recommendations for these three stocks that I believe will beat even the monster 30-times-your-money profits my readers have already booked three times now.

You’ll get my insights on three new companies from conversations with my network of cannabis industry insiders.

You’ll get why these companies are especially primed to deliver millionaire-maker windfall profits as the end of pot prohibition comes in America.

You’ll get my full analysis on all three stocks and why they’re a perfect fit for this strategy.

I’ve put everything you need to know into "The Kennedy Blueprint: Three Millionaire-Maker Stocks for The End of Pot Prohibition."

If I sold this report, it would be worth at least $299.

After all, what’s it worth to you to have an exact blueprint that could turn every $1,000 into $30,000 — and every $35,000 into more than a million?

Surely far more than $299.

But I’d like to extend you a special offer —and give you the report FREE.

Try My Green Chip Stocks Service For the Next 30 Days and "The Kennedy Blueprint" Is Yours Free...

This is an opportunity to get your hands on all of my in-depth research and marijuana stock recommendations as cannabis legalization continues throughout the U.S. and the world.

Green Chip Stocks the only place I’m offering this kind of research into the biggest profit opportunities in pot stocks.

Every week, you’ll hear from me with easy-to-follow buy and sell recommendations for the specific pot stocks that can give you hundreds and even thousands of percent gains.

You’ll discover which companies could make you a mint (or a marijuana millionaire).

You’ll hear about my meetings with company executives, investors, and other industry insiders — and what that means for you.

You’ll hear what’s going on in the fast-moving process of marijuana legalization.

And you’ll get the latest news and updates on all the stocks I’m following in "The Kennedy Blueprint: Three Millionaire-Maker Stocks for The End of Pot Prohibition" plus the full Green Chip Stocks portfolio.

Your updates will be delivered to you privately by email. Plus, you can access them any time through the Green Chip Stocks members website.

I'll Also Let You Into My Network of Cannabis Industry Insiders...

You can connect online...

First off, you’ll have access to me personally through private email. You can contact me directly and ask me any questions you have.

While I can’t give you personalized investment advice, these questions often make their way into my member alerts, and you can have your questions answered.

Plus when I’m not immediately able to answer the question myself, I’ll reach out to my network and get the answer. That means you have the benefit of not just me but my entire contact list.

And even better…

You can meet us in-person...

I’ll invite you to personally meet my contacts at private events and facility tours.

I host an annual Green Chip Stocks member event where I invite members of my network throughout the marijuana business to meet and share with members.

Companies present their latest updates, answer your questions, and give you an opportunity to meet-and-greet. We wrap up the day with a gourmet dinner, where we can talk over some great food and fine wine.

Can’t make the event? Don’t worry, videos of the presentations and group discussions are included free on our private members-only website.

You can even join me on-site...

A few times a year, you’ll be invited to join me on private member-only trips. This gives you a rare opportunity to see firsthand what’s going on behind the scenes of the companies we invest in.

During these trips we could tour a research lab, swing by a dispensary, and even sit in private meetings with CEOs and other executives.

These live events alone could easily justify a $1,499 price tag and are an unprecedented member benefit for a service like Green Chip Stocks.

And yet you get them free of charge.

So, as you can see, Green Chip Stocks is more than just a pot stock-picking service. It’s a true community of investors who want to come together and grow rich from this massive legalization wave sweeping the country.

There’s nothing else like it.

And I want you to be my next success story...

Which is why I work tirelessly to give you everything you need to make your own personal fortune from pot stocks.

I'll Give You the Lowest Price Ever to Get in the Door

Of course, you may assume that with the huge upside profit opportunities available to you as a member, Green Chip Stocks would be, at a minimum, a $2,000 or $3,000 service. But it’s not.

I believe that as individual investors and everyday Americans, we have a once-in-a-lifetime opportunity to create truly life-changing wealth from the end of pot prohibition.

And I don’t want to put so big of a price tag on this that you get pushed out.

So I insisted to my publisher that we keep this ultra-affordable, and we settled on the retail rate of just $199 per year.

But you don’t even have to pay half of that today with this special invitation.

In addition to your free copy of "The Kennedy Blueprint: Three Millionaire-Maker Stocks for The End of Pot Prohibition," all the member benefits, and the free live events...

I want to offer you just over 50% off the price of your first year of Green Chip Stocks membership, with an introductory price of just $99 for a whole year.

That’s only $0.27 a day to have access to all my breakthrough investment research and every exclusive member-only benefit.

Not only that, remember — I want you to simply try Green Chip Stocks for the next 30 days.

You’ll see how fast we’re moving toward the end of pot prohibition — and discover your best shots at making as much as 3,000%+ profits.

I’m certain that within 30 days, you’ll see for yourself how valuable it is to have me in your corner through Green Chip Stocks, how fast this market is moving at the end of pot prohibition, and why this is your single-best shot at becoming a millionaire today with just a small investment stake.

And I’m certain you’ll want to keep your membership.

But if you decide for any reason that it’s not for you, you can cancel your membership — no questions asked. Simply let our member services team know, and you’ll get a prompt and courteous full refund.

And you can even keep your free copy of "The Kennedy Blueprint: Three Millionaire-Maker Stocks for The End of Pot Prohibition" without obligation, as my thank you for giving Green Chip Stocks an honest try.

Plus, I’ll give you one MORE way to profit from marijuana legalization... by going international. When you join Green Chip Stocks, I’ll send you another bonus report, called "Marijuana Millionaire International: Get Rich off the Worldwide End of Pot Prohibition." In it, you’ll get the full scoop on two hot international pot profit opportunities.

This report is valued at $199. But again, it’s yours free, along with everything else, when you simply try Green Chip Stocks for the next 30 days.

I'm Giving Away The Farm...

Let’s recap everything you’re getting today…

  • "The Kennedy Blueprint: Three Millionaire-Maker Stocks for The End of Pot Prohibition"— a $299 value.
  • "Marijuana Millionaire International: Get Rich off the Worldwide End of Pot Prohibition"— a $199 value.
  • 12 months of full access to Green Chip Stocks exclusive research, investment portfolio, urgent weekly updates, new recommendations, and more — a $1,999 value.
  • Invites to my live events and site tours, plus recordings of past events — a $1,499 value.
  • And a big 50% savings off the $199 retail membership rate.

When you add it all up, it’s a $3,996 value.

But you’ll pay just pennies on the dollar — just $99 today.

There’s only one caveat... you’ll want to move quickly.

And remember...

You're trying it 100% risk-free for the next 30 days.

So, let’s not waste another second. Just click here now to get started.

See for yourself how my top three pot stocks are positioned to turn you into a marijuana millionaire as we speed toward the end of pot prohibition in the U.S.

Check out my full research on how to get rich off legalization in Mexico and Europe, plus the rest of the Green Chip Stocks portfolio.

And if you’re like most of our subscribers, chances are, you’ll want to continue getting this cutting-edge research and investment advice for a long time.

Just click here now to get access to your special reports and everything you need to get started making money from pot stocks right now.

You’ll be taken to a secure sign-up page, where you can review all the details on how to join us for the next round's massive pot stock profits.

I look forward to welcoming you inside Green Chip Stocks in the next few minutes.

To a new way of life and a new generation of wealth...

Jeff Siegel Signature

Jeff Siegel

follow basic@JeffSiegel on Twitter

Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.


Energy and Capital, Copyright © 2019, Angel Publishing LLC. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our Privacy Policy. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Energy and Capital does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.